NitroMed: In the NO

NitroMed: In the NO

Basic biochemical research often uncovers potential therapeutic targets in unusual places. The elucidation of signaling pathways involving nitric oxide (NO), a short-lived gas, surprised many academic scientists. Since being named Science magazine's 1992 molecule of the year, NO is now recognized as a widely-used signaling molecule.

NitroMed Inc. is taking advantage of NO signaling to modify and improve existing compounds or approved drugs in disease areas that would benefit from local delivery of nitric

Read the full 782 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE